Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2002 4
2003 6
2004 5
2005 2
2006 4
2007 2
2008 5
2009 8
2010 8
2011 3
2012 8
2013 11
2014 10
2015 12
2016 9
2017 8
2018 8
2019 7
2020 9
2021 12
2022 9
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
TLR7 gain-of-function genetic variation causes human lupus.
Brown GJ, Cañete PF, Wang H, Medhavy A, Bones J, Roco JA, He Y, Qin Y, Cappello J, Ellyard JI, Bassett K, Shen Q, Burgio G, Zhang Y, Turnbull C, Meng X, Wu P, Cho E, Miosge LA, Andrews TD, Field MA, Tvorogov D, Lopez AF, Babon JJ, López CA, Gónzalez-Murillo Á, Garulo DC, Pascual V, Levy T, Mallack EJ, Calame DG, Lotze T, Lupski JR, Ding H, Ullah TR, Walters GD, Koina ME, Cook MC, Shen N, de Lucas Collantes C, Corry B, Gantier MP, Athanasopoulos V, Vinuesa CG. Brown GJ, et al. Among authors: lopez af. Nature. 2022 May;605(7909):349-356. doi: 10.1038/s41586-022-04642-z. Epub 2022 Apr 27. Nature. 2022. PMID: 35477763 Free PMC article.
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial.
Perez-Moreiras JV, Gomez-Reino JJ, Maneiro JR, Perez-Pampin E, Romo Lopez A, Rodríguez Alvarez FM, Castillo Laguarta JM, Del Estad Cabello A, Gessa Sorroche M, España Gregori E, Sales-Sanz M; Tocilizumab in Graves Orbitopathy Study Group. Perez-Moreiras JV, et al. Am J Ophthalmol. 2018 Nov;195:181-190. doi: 10.1016/j.ajo.2018.07.038. Epub 2018 Aug 4. Am J Ophthalmol. 2018. PMID: 30081019 Clinical Trial.
Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia.
Kan WL, Dhagat U, Kaufmann KB, Hercus TR, Nero TL, Zeng AGX, Toubia J, Barry EF, Broughton SE, Gomez GA, Benard BA, Dottore M, Cheung Tung Shing KS, Boutzen H, Samaraweera SE, Simpson KJ, Jin L, Goodall GJ, Begley CG, Thomas D, Ekert PG, Tvorogov D, D'Andrea RJ, Dick JE, Parker MW, Lopez AF. Kan WL, et al. Among authors: lopez af. Cancer Discov. 2023 Aug 4;13(8):1922-1947. doi: 10.1158/2159-8290.CD-22-1396. Cancer Discov. 2023. PMID: 37191437 Free PMC article.
Understanding mast cell heterogeneity at single cell resolution.
Cildir G, Yip KH, Pant H, Tergaonkar V, Lopez AF, Tumes DJ. Cildir G, et al. Among authors: lopez af. Trends Immunol. 2021 Jun;42(6):523-535. doi: 10.1016/ Epub 2021 May 4. Trends Immunol. 2021. PMID: 33962887 Review.
Messing with βc: A unique receptor with many goals.
Kan WL, Cheung Tung Shing KS, Nero TL, Hercus TR, Tvorogov D, Parker MW, Lopez AF. Kan WL, et al. Among authors: lopez af. Semin Immunol. 2021 Apr;54:101513. doi: 10.1016/j.smim.2021.101513. Epub 2021 Nov 24. Semin Immunol. 2021. PMID: 34836771 Review.
Dual inhibition of airway inflammation and fibrosis by common β cytokine receptor blockade.
Wang H, Yip KH, Keam SP, Vlahos R, Nichol K, Wark P, Toubia J, Kral AC, Cildir G, Pant H, Hercus TR, Wilson N, Owczarek C, Lopez AF, Bozinovski S, Tumes DJ. Wang H, et al. Among authors: lopez af. J Allergy Clin Immunol. 2024 Mar;153(3):672-683.e6. doi: 10.1016/j.jaci.2023.10.021. Epub 2023 Nov 4. J Allergy Clin Immunol. 2024. PMID: 37931708 Free article.
Signalling by the βc family of cytokines.
Hercus TR, Dhagat U, Kan WL, Broughton SE, Nero TL, Perugini M, Sandow JJ, D'Andrea RJ, Ekert PG, Hughes T, Parker MW, Lopez AF. Hercus TR, et al. Among authors: lopez af. Cytokine Growth Factor Rev. 2013 Jun;24(3):189-201. doi: 10.1016/j.cytogfr.2013.03.002. Epub 2013 Mar 25. Cytokine Growth Factor Rev. 2013. PMID: 23535386 Review.
ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism.
Boyle ST, Poltavets V, Kular J, Pyne NT, Sandow JJ, Lewis AC, Murphy KJ, Kolesnikoff N, Moretti PAB, Tea MN, Tergaonkar V, Timpson P, Pitson SM, Webb AI, Whitfield RJ, Lopez AF, Kochetkova M, Samuel MS. Boyle ST, et al. Among authors: lopez af. Nat Cell Biol. 2020 Jul;22(7):882-895. doi: 10.1038/s41556-020-0523-y. Epub 2020 May 25. Nat Cell Biol. 2020. PMID: 32451439
143 results